Curt Watkins, MD
Allergy & Immunology · Salisbury, MDNPI 1194787689
Payments from drug & device makers
Across 490 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$1K
- Sanofi$1K
- Novartis$828
- Regeneron Healthcare Solutions, Inc.$751
- Pfizer$515
- plus $3K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 104 | $2,177 |
| GSK | 85 | $1,348 |
| Sanofi | 43 | $1,005 |
| Novartis | 43 | $828 |
| Regeneron Healthcare Solutions, Inc. | 32 | $751 |
| Pfizer | 26 | $515 |
| CSL Behring | 23 | $478 |
| Amgen(2 entities) | 22 | $389 |
| Genentech USA, Inc. | 20 | $357 |
| Pharming Healthcare, Inc. | 16 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $315 |
| Biocryst US Sales Co., LLC | 13 | $252 |
| Grifols USA, LLC | 12 | $232 |
| Sanofi-aventis U.S. LLC | 3 | $205 |
| Aimmune Therapeutics, Inc. | 8 | $118 |
| Blueprint Medicines Corporation | 3 | $79 |
| Ionis Pharmaceuticals, Inc. | 3 | $75 |
| Boehringer Ingelheim | 4 | $65 |
| AbbVie | 3 | $64 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $46 |
| Octapharma USA, Inc. | 2 | $40 |
| Cycle Pharmaceuticals Inc | 2 | $37 |
| USWM, LLC | 1 | $29 |
| LEO Pharma Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $21 |
| Merck | 1 | $20 |
| Incyte Corporation | 1 | $18 |
| Biocryst Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$9,873 in reported general payments places this provider in the 75th percentile of 105 allergy & immunology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Salisbury
- Adrienne YanceySalisbury$2K
- Mark ScarupaWheaton$1.2M
- Antoine AzarBaltimore$990K
- Melanie DispenzaBaltimore$866K
- Gordon RaphaelBethesda$752K
- Matthew MardineyBel Air$643K
- Sudhir SekhsariaRockville$565K
- Manav SinglaWhite Marsh$506K
- Sally BaileyBaltimore$358K
- Luke PittmanBethesda$282K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.